T1	Participants 72 102	esophageal carcinoma in Asians
T2	Participants 273 285	Asian people
T3	Participants 453 513	Patients of resectable esophageal cancer of comparable stage
T4	Participants 679 698	Discharged patients
T5	Participants 1146 1275	eighty-seven patients of stage II and III, including 71 patients of middle third lesions and 16 lower third lesions were enrolled
